The Asia Pacific Cold And Flu Supplements Market should witness market growth of 12.5% CAGR during the forecast period (2023-2030).
A rise in spending power and population is another factor influencing market expansion. As private and public entities focus their research & development efforts on creating drug delivery systems and effective medications that can be bought at the neighborhood pharmacy, medical supply store, or online, the opportunity for the market to expand is likely to rise.
Supplements can be purchased over the counter and are available without a prescription. These supplements comprise cough suppressants and antihistamines. Colds can be prevented and treated with the help of the herbal supplement echinacea. As an immune system booster, this herb is recommended. Due to its immune-boosting and antioxidant characteristics, elderberry is frequently used to treat the flu. Many patients use garlic to prevent the symptoms of the common cold. Both Panax ginseng and Panax quinquefolium have been investigated for their capacity to cure upper respiratory tract infections, known as a water-soluble vitamin, vitamin C.
A soluble vitamin called zinc is essential for numerous physiological functions. Cold replication virus is prevented by zinc. It has been shown that using zinc supplements can aid in treating and preventing the common cold. The demand for cold and flu supplements has increased significantly because of changing lifestyles and improved access to supplements through both online and physical retailers. Another element fueling this market is consumers' growing awareness of the medical benefits and features of natural medicines.
Asia-Pacific is anticipated to capture a sizable portion of the market due to a growing awareness of patients' health, particularly in Japan, China, and South Korea. Chinese traditional remedies are also becoming increasingly common all over the world as a way to increase immunity. Additionally, middle-class people in developing nations like China and India are spending more on items that are used as a preventative measure against illness, like immunity-boosting vitamins and minerals. Due to this, the market will grow steadily throughout the region in the projection period.
The China market dominated the Asia Pacific Cold And Flu Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,964.5 million by 2029. The Japan market anticipated to grow at a CAGR of 11.8% during (2023-2030). Additionally, India's market would register a CAGR of 13.2% during (2023-2030).
Based on Product, the market is segmented into Vitamins & Minerals, Herbal Extracts, and Natural Molecules. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Hypermarkets & Supermarkets, Online, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
A rise in spending power and population is another factor influencing market expansion. As private and public entities focus their research & development efforts on creating drug delivery systems and effective medications that can be bought at the neighborhood pharmacy, medical supply store, or online, the opportunity for the market to expand is likely to rise.
Supplements can be purchased over the counter and are available without a prescription. These supplements comprise cough suppressants and antihistamines. Colds can be prevented and treated with the help of the herbal supplement echinacea. As an immune system booster, this herb is recommended. Due to its immune-boosting and antioxidant characteristics, elderberry is frequently used to treat the flu. Many patients use garlic to prevent the symptoms of the common cold. Both Panax ginseng and Panax quinquefolium have been investigated for their capacity to cure upper respiratory tract infections, known as a water-soluble vitamin, vitamin C.
A soluble vitamin called zinc is essential for numerous physiological functions. Cold replication virus is prevented by zinc. It has been shown that using zinc supplements can aid in treating and preventing the common cold. The demand for cold and flu supplements has increased significantly because of changing lifestyles and improved access to supplements through both online and physical retailers. Another element fueling this market is consumers' growing awareness of the medical benefits and features of natural medicines.
Asia-Pacific is anticipated to capture a sizable portion of the market due to a growing awareness of patients' health, particularly in Japan, China, and South Korea. Chinese traditional remedies are also becoming increasingly common all over the world as a way to increase immunity. Additionally, middle-class people in developing nations like China and India are spending more on items that are used as a preventative measure against illness, like immunity-boosting vitamins and minerals. Due to this, the market will grow steadily throughout the region in the projection period.
The China market dominated the Asia Pacific Cold And Flu Supplements Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,964.5 million by 2029. The Japan market anticipated to grow at a CAGR of 11.8% during (2023-2030). Additionally, India's market would register a CAGR of 13.2% during (2023-2030).
Based on Product, the market is segmented into Vitamins & Minerals, Herbal Extracts, and Natural Molecules. Based on Distribution Channel, the market is segmented into Pharmacies & Drug Stores, Hypermarkets & Supermarkets, Online, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Nordic Naturals, Inc., Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG), Pfizer, Inc., Amway Corporation, NOW Foods, Inc., Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.), Neurobiologix, Inc., Himalaya Global Holdings Ltd., Nu Skin Enterprises, Inc., and Nature’s Sunshine Products, Inc.
Scope of the Study
By Product
- Vitamins & Minerals
- Herbal Extracts
- Natural Molecules
By Distribution Channel
- Pharmacies & Drug Stores
- Hypermarkets & Supermarkets
- Online
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Nordic Naturals, Inc.
- Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- Pfizer, Inc.
- Amway Corporation
- NOW Foods, Inc.
- Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
- Neurobiologix, Inc.
- Himalaya Global Holdings Ltd.
- Nu Skin Enterprises, Inc.
- Nature’s Sunshine Products, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Cold And Flu Supplements Market by Product
Chapter 5. Asia Pacific Cold And Flu Supplements Market by Distribution Channel
Chapter 6. Asia Pacific Cold And Flu Supplements Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Nordic Naturals, Inc.
- Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG)
- Pfizer, Inc.
- Amway Corporation
- NOW Foods, Inc.
- Wakunaga of America Co., Ltd. (Wakunaga Pharmaceutical Co., Ltd.)
- Neurobiologix, Inc.
- Himalaya Global Holdings Ltd.
- Nu Skin Enterprises, Inc.
- Nature’s Sunshine Products, Inc.
Methodology
LOADING...
